Avalo Therapeutics (AVTX) FCF Margin (QoQ) (2016 - 2024)
Avalo Therapeutics (AVTX) FCF Margin (QoQ) (2016 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Avalo Therapeutics | 1.04 Mn | 1.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | -320,610.00 |
| Dec 31, 2023 | 241,220.00 |
| Sep 30, 2023 | -118,184.00 |
| Jun 30, 2023 | 43,470.00 |
| Mar 31, 2023 | -169,914.00 |
| Dec 31, 2022 | -48,901.00 |
| Sep 30, 2022 | 125,126.00 |
| Jun 30, 2022 | 15,715.00 |
| Mar 31, 2022 | 598,141.00 |
| Dec 31, 2021 | -599,788.00 |
| Sep 30, 2021 | -78,137.00 |
| Jun 30, 2021 | 330,485.00 |
| Mar 31, 2021 | -291,228.00 |
| Dec 31, 2020 | 10,394.00 |
| Sep 30, 2020 | -42,902.00 |
| Jun 30, 2020 | -43,100.00 |
| Mar 31, 2020 | -16,635.00 |
| Dec 31, 2019 | 30,414.00 |
| Sep 30, 2019 | 14,013.00 |
| Jun 30, 2019 | -35,870.00 |